BabyBIG
Generic: botulism immune globulin intravenous (human)
Manufacturer: California Department of Public Health · Program:
Apply for AssistanceEligibility Criteria
Insurance Requirement
See program details
Residency
US patients (provided internationally at IBTPP discretion)
No patient assistance program; provided free through state program to eligible patients
Program Information
Processing Time
2–8 weeks
Delivery Method
shipped to hospital via FFF Enterprises
Application Method
Online
Typically Required Documents
ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.
- physician request
- clinical consultation
Indicated For
infant botulism
About This Medication
# Infant Botulism Treatment and Prevention Program Patient Guide: How to Get BabyBIG at No Cost ## About BabyBIG BabyBIG (Botulism Immune Globulin Intravenous [Human]) is the only FDA-approved treatment for infant botulism caused by Clostridium botulinum toxin types A or B in infants under 12 months of age. Infant botulism is a serious condition that occurs when a baby swallows bacteria that grow in the gut and produce botulinum toxin. Early symptoms include constipation, difficulty feeding, a weak cry, and loss of head control, which can progress to descending paralysis requiring hospitalization and sometimes mechanical ventilation. BabyBIG works by containing human-derived antibodies that bind to and neutralize circulating botulinum neurotoxins, preventing further damage to the neuromuscular junction. While it halts disease progression, it does not reverse existing symptoms. Treatment should be administered as soon as infant botulism is suspected—do not wait for confirmatory stool testing results. ## Who Qualifies for BabyBIG BabyBIG is provided at **no cost** to eligible patients through the California Department of Public Health's Infant Botulism Treatment and Prevention Program (IBTPP). There is no patient assistance program application process because the medication is supplied directly by the state to hospitals treating eligible infants. **Eligibility Requirements:** - Infant is under 12 months of age - Infant has clinically suspected or confirmed infant botulism caused by toxin type A or B - Treating physician requests the medication through the IBTPP There are **no income thresholds, insurance requirements, or financial eligibility criteria**. All eligible infants receive BabyBIG regardless of family income or insurance status. ## Income Eligibility BabyBIG is provided free to all eligible patients through a state-funded program. There are no income limits or financial eligibility requirements. Families do not need to demonstrate financial need or meet any income thresholds to receive this treatment. | Eligibility Factor | Details | |---|---| | Income Limits | None—all eligible patients receive BabyBIG at no cost | | Insurance Required | No—coverage is provided regardless of insurance status | | Financial Documentation | Not required | | Cost to Patient | $0 | ## Insurance Requirements There are **no insurance requirements** to receive BabyBIG. The medication is provided free through the state program to all eligible infants, regardless of whether they have private insurance, Medicaid, Medicare, or no insurance. Insurance status does not affect eligibility or cost. ## How to Apply: Step-by-Step Process ### Step 1: Seek Immediate Medical Attention If you suspect your infant has botulism, **call 911 or go to the nearest emergency room immediately**. Do not delay seeking care. Symptoms include constipation, difficulty feeding, weak cry, and loss of head control. ### Step 2: Clinical Diagnosis and Physician Request Your infant's treating physician will evaluate your baby for infant botulism. If botulism is suspected or confirmed, the physician will contact the IBTPP directly to request BabyBIG. **You do not need to submit an application yourself**—your physician handles the entire process. ### Step 3: Clinical Consultation The IBTPP provides 24/7 clinical consultation to the treating physician. During this consultation, the physician and IBTPP staff will: - Confirm the clinical diagnosis - Verify the infant's eligibility - Determine the appropriate dosage based on the infant's weight - Arrange rapid shipment of BabyBIG ### Step 4: Medication Delivery BabyBIG is shipped directly to the hospital by FFF Enterprises, the exclusive distributor. The medication arrives as a lyophilized powder that must be reconstituted before intravenous administration. ### Step 5: Treatment Administration The recommended dose is 50 mg/kg (1.0 mL/kg) given as a single intravenous infusion as soon as the clinical diagnosis is made. Hospital pharmacy and nursing staff will prepare and administer the medication. ## Required Documentation Your physician will need to provide: - **Physician request** for BabyBIG - **Clinical consultation** with IBTPP staff to confirm diagnosis and eligibility You do not need to submit financial documents, insurance information, or income verification. The IBTPP does not require any patient paperwork for approval. ## Timeline and Delivery **Processing Time:** Immediate to same-day BabyBIG is treated as a medical emergency. Once your physician contacts the IBTPP and clinical consultation confirms eligibility, the medication is shipped rapidly to your hospital. The IBTPP operates 24 hours a day, 7 days a week, 365 days a year to ensure rapid access to treatment. **Delivery Method:** Shipped directly to the hospital via FFF Enterprises **Cost:** $0 to the patient and family ## What If Your Application Is Denied Denials are extremely rare because there are no eligibility barriers beyond clinical diagnosis and age. If your physician's request is not approved, it would typically be because: - The infant is over 12 months of age (BabyBIG is only approved for infants under 12 months) - The diagnosis is not infant botulism caused by toxin type A or B - The infant has already received BabyBIG for this episode If your request is denied, the IBTPP clinical staff will explain the reason and discuss alternative treatment options with your physician. ## Reauthorization and Refills **Reauthorization is not required.** BabyBIG is a one-time treatment given as a single intravenous infusion. Your infant will not need to reapply or seek reauthorization for additional doses of BabyBIG for the same episode of botulism. If your infant develops a new case of botulism in the future (which is extremely rare), your physician would need to contact the IBTPP again to request treatment. ## Contact Information **Infant Botulism Treatment and Prevention Program (IBTPP)** - **Phone:** (510) 231-7600 (24/7/365) - **Fax:** (510) 231-7609 - **Email:** IBTPP@infantbotulism.org - **Website:** www.infantbotulism.org **For Parents and Caregivers:** - **Hotline:** 1-833-398-2022 (trained staff available to answer questions) ## Important Disclaimer This guide provides general information about BabyBIG and the IBTPP program. It is not a substitute for medical advice. If you believe your infant has botulism, seek emergency medical care immediately by calling 911 or going to the nearest emergency room. Your physician will determine whether BabyBIG is appropriate for your infant's condition. All treatment decisions should be made in consultation with your healthcare provider. For the most current information about BabyBIG and the IBTPP, visit www.infantbotulism.org or call the IBTPP directly.
Program information last verified: March 30, 2026
Ready to apply for BabyBIG assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.